Vistra has been appointed the fund administrator for global venture capital fund, AMR Action Fund.
The AMR Action Fund, the world’s largest public-private partnership supporting the development of new antibiotics, selected Vistra’s multi-country, multi-service solution to help with its goal to bring two to four new antibiotics to the market by the end of this decade.
AMR Action Fund is an initiative of the international body representing the R&D pharmaceutical industry (International Federation of Pharmaceutical Manufacturers & Associations, IFPMA), in collaboration with the World Health Organisation, the European Investment Bank, and the Wellcome Trust.
By investing more than $1 billion in smaller biotech companies and providing industry expertise to support the clinical development of novel antibiotics, AMR Action Fund helps accelerate the development of new antibiotics.
Vistra, with $370 billion of assets under administration, will support the AMR Action Fund across its entire fund structure, the management company, its SPVs and portfolio company investments.
The services provided by Vistra will also enable the AMR Action Fund to focus on sourcing the investments across their US and Luxembourg funds.
“Combining our global fund administration expertise with our corporate and advisory services into one tailored solution was key to helping the AMR Action Fund to build their operations quickly across the world – ensuring strong foundations were put in place while complying with all the required regulations,” said Onno Bouwmeister, global head of private equity and real estate at Vistra.
“We’re delighted that Vistra has been able to provide these essential services so that the AMR Action Fund can focus their efforts on what they do best – making the right investments to address an important health issue.”
Last month, Vistra won an administration mandate from UK-based Ethos Invest for its new Financial Services & Technologies fund. The new fund aims to be the world’s largest sharia-compliant, tech-focussed private equity fund.